Developing Methods for Reconstructing Electrical Heart Activity
NCT ID: NCT03947021
Last Updated: 2021-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
65 participants
INTERVENTIONAL
2012-01-31
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
NCT03200132
Multicenter Imaging in Lead Extraction Study
NCT03772704
The Use of Myocardial Deformation Imaging
NCT00476320
Cardiac MR (CMR) in Cardiac Resynchronization Therapy Non-responders
NCT01367691
MRI Assessment of Arrythmia Ablation Lesions
NCT02761343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BSPM-only group
Participants will only receive body-surface potential mapping (BSPM) with an extensive electrode set (256 electrodes).
Body-surface potential mapping
Measurement of 256-lead body-surface electrocardiogram
CT+BSPM group
Participants will receive body-surface potential measurements (BSPM) and a CT scan. These data will allow for non-invasive reconstruction of electrical potentials at the heart surface.
Computed tomography (CT) scan
A CT scan of thorax and heart will be performed in the CT+BSPM group.
Body-surface potential mapping
Measurement of 256-lead body-surface electrocardiogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computed tomography (CT) scan
A CT scan of thorax and heart will be performed in the CT+BSPM group.
Body-surface potential mapping
Measurement of 256-lead body-surface electrocardiogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to provide informed consent
* Conditions that might alter electrical conduction properties in the heart, including (but not limited to): Brugada syndrome (BS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), demonstrated ventricular arrhythmias (resuscitation, (non)sustained ventricular tachycardia, ventricular fibrillation)
* Implanted cardiac device, such as pacemaker or implantable cardioverter defibrillator
\- Existing medical indication for a cardiac CT scan unrelated to this research
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Center
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHS 2007T51
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
METC 11-2-043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.